Dabigatran and Aspirin: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Dabigatran
Aspirin
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Increased risk of bleeding
Interaction Deep Dive
Dabigatran etexilate can cause significant and, sometimes, fatal bleeding. Risk is further increased with concomitant use of drugs that also increase the risk of bleeding, including antiplatelet agents. Promptly evaluate any signs or symptoms of blood loss and discontinue use of dabigatran etexilate in patients with active pathological bleeding1. In patients with DVT and/or PE and stable cardiovascular disease receiving aspirin for cardiovascular risk modification, suspending aspirin for the duration of anticoagulation therapy for DVT and/or PE is suggested (conditional recommendation, very low certainty of evidence); however, this does not apply to patients with a recent acute coronary event or intervention 2. In a pooled analysis of 3 randomized trials, no significant difference in major bleeding events occurred in patients undergoing total hip and total knee arthroplasty receiving dabigatran and aspirin compared with dabigatran alone for 6 to 35 days 4.
Why it happens (mechanism)
Additive effects on hemostasis
Literature reports
2 reports — tap to read
a) Concomitant use of direct oral anticoagulant (DOAC) and antiplatelet therapy (APT; n=78) compared to DOAC therapy alone (n=329) did not significantly alter the incidence of major bleeding (1.3% vs 1.2%) or clinically relevant non-major bleeding (10.2% vs 6.4%) over 6 months of treatment in a retrospective study. Patients were primarily Caucasian men with a mean age of 63.7 years. Patients receiving concurrent APT had significantly higher mean body mass index (30.7 vs 28.4), mean CHA2DS2-VASc score (4.28 vs 3.85), and were more likely to have diabetes (26.9% vs 17.3%) compared to those prescribed DOAC monotherapy. DOACs were prescribed for VTE treatment or atrial fibrillation, and included apixaban (58.5%), rivaroxaban (38.1%), and dabigatran (3.4%). Single antiplatelet therapy was utilized in 94.9% (74 patients), with aspirin 81 mg once daily as the most common regimen (69 patients). Other APT regimens included aspirin 81 mg twice daily (3 patients), aspirin 325 mg daily (1 patient), clopidogrel 75 mg daily (1 patient), and dual APT with aspirin 81 mg and clopidogrel 75 mg daily (4 patients) 3.
b) In a pooled analysis of 3 randomized trials (N=8135), no significant difference in major bleeding events occurred in patients undergoing total hip and total knee arthroplasty receiving dabigatran and aspirin compared with dabigatran alone (dabigatran 220 mg [OR, 1.14; 95% CI, 0.26 to 5.03, n=126] and dabigatran 150 mg [OR, 1.64; 95% CI, 0.36 to 7.49; n=128]). Patients within this analysis received dabigatran and less than 160 mg/day of aspirin for 6 to 35 days. Additionally, there were no differences in the rates of total VTE or all cause mortality, or of major VTE or VTE-related mortality in patients taking concomitant aspirin or NSAIDs compared with dabigatran alone within the study 4.
Common questions
Can I take Dabigatran and Aspirin together?
Increased risk of bleeding Always confirm with your pharmacist or prescriber before making any change.
How serious is the Dabigatran and Aspirin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Dabigatran or Aspirin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: PRADAXA(R) oral capsules, dabigatran etexilate oral capsules. Boehringer Ingelheim Pharmaceuticals Inc (per FDA), Ridgefield, CT, 2023. DailyMed
- Ortel TL, Neumann I, Ageno W, et al: American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv 2020; 4(19):4693-4738. PubMed
- Tinkham TT, Vazquez SR, Jones AE, et al: Direct oral anticoagulant plus antiplatelet therapy: prescribing practices and bleeding outcomes. J Thromb Thrombolysis 2020; 49(3):492-496. PubMed
- Friedman RJ, Kurth A, Clemens A, et al: Dabigatran etexilate and concomitant use of non-steroidal anti-inflammatory drugs or acetylsalicylic acid in patients undergoing total hip and total knee arthroplasty: no increased risk of bleeding. Thromb Haemost 2012; 108(1):183-190. DOI
Keep reading about Dabigatran
Keep reading about Aspirin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist